Connect with us

featured

NORML Op-Ed: Take Marijuana Off the Streets and Put It Behind the Counter

Published

on


Marijuana Dispensary

Police in Warwick, Rhode Island recently walked back claims that exposure to “fentanyl-laced cannabis” was responsible for a local woman’s tragic overdose death.

Such sensational pronouncements, followed by far less publicized refutations, are nothing new.

A case in point: Police in Brattleboro, Vermont generated headlines in 2021 when they arrested multiple people on charges of distributing fentanyl-tainted cannabis. Days later, however, lab tests confirmed that no fentanyl was present in any of the marijuana samples seized by law enforcement.

A similar, highly publicized scenario unfolded in Connecticut, where officials alleged that marijuana laced with fentanyl was responsible for over three dozen overdose incidents. Forensic analyses later determined that only one of these cases actually involved the ingestion of fentanyl. (That case, health officials said, was probably the result of accidental contamination.)

According to a 2023 report issued by New York State’s Office of Cannabis Management: “Misinformation related to the danger of accidental overdose due to cannabis ‘contaminated’ with fentanyl remains widespread.” These claims “continue to be found to be false, as of the date of this publication.”

In fact, a recent Harvard Medical School study revealed that forensic labs almost never find fentanyl in illicit cannabis seizures. “Our results show no evidence of widespread fentanyl co-occurrence with cannabis,” the study’s authors concluded.

That’s not to say that some unregulated cannabis products aren’t without their own quality control issues.

For instance, a recent scientific analysis of unregulated cannabis flowers seized by police determined that 16 percent of samples “had detectable levels of mycotoxins and fungal metabolites.”

Some hemp-derived cannabinoid products, which are often sold at gas stations and ‘smoke shops’ and aren’t typically subject to any state or federal regulations, have been found to contain unlabeled cutting agents and potentially dangerous heavy metals — including magnesium, chromium, nickel, and mercury.

Some commercially available CBD products, which are also largely unregulated, have also been found to contain psychoactive additives, including dextromethorphan, a common cough suppressant.

In addition, these unregulated products often contain far higher or lower percentages of the active ingredients identified on their labels. As a result, consumers may be getting far more — or in other instances, far less — than they bargained for.

The solution to these quality control issues isn’t to amplify sensational (and often fictitious) claims about tainted weed. It’s to eliminate consumers’ exposure to potentially adulterated or mislabeled products by legalizing and regulating cannabis manufacturing and sales.

Under state regulations governing the adult-use and medical cannabis markets, products are made available from licensed manufacturers at state-licensed retail stores. This cannabis is cultivated, and these products are manufactured, in accordance with good manufacturing practices. Products are lab tested and labeled accordingly — ensuring that consumers have access to products of verified purity and potency.

As these state-legal markets mature, they disrupt the unregulated cannabis marketplace. According to a 2023 survey, 52 percent of consumers residing in legal states said that they primarily sourced their cannabis products from brick-and-mortar establishments. By contrast, only 6 percent of respondents said that they primarily purchased cannabis from a “dealer.”

In Canada, which legalized cannabis sales nationwide five years ago, some 70 percent of consumers report purchasing marijuana products exclusively from the legal marketplace. Further, jurisdictions that have legalized marijuana markets see declines in the use of both synthetically produced and unregulated, hemp-derived cannabis products.

Will marijuana legalization bring an end to the fentanyl crisis? No. But by taking cannabis products off street corners and placing them behind the counter, lawmakers are providing cannabis consumers with safer experiences and greatly reducing their risk of being inadvertently exposed to contaminated products.

A version of this commentary was initially published by Other Words.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

featured

Ozzy Osbourne, Parkinson’s and the Promise of Magic Mushrooms: Could They Have Helped?

Published

on


It was in 2002 when I met Ozzy Osbourne.

I was on the side of the stage as he was preparing to perform. Thanks to a brief stint as a touring musician that got me backstage access to Ozzfest in 2002, I had the privilege of watching the inner workings of that fine-tuned music festival from a vantage point few will ever know.

Also read: From The Vault: THE WISDOM OF OZ (1999)

To be clear, I didn’t actually “meet” Ozzy. He just walked next to me as I stood starstruck. Something that doesn’t happen to me often, by the way. He looked back and waved to me. I think he clearly recognized my excitement and threw me a bone. I suppose this was just part of his life, though: acknowledging his fans without a fuss or any sense of self-importance. And I think that’s one of the reasons so many people loved Ozzy. It’s one thing to be a music legend. It’s another thing to be a music legend while also just being a kind and decent person who loved his fans as much as we loved him. And he vocalized that love, which is why I think his death hit us all so hard.

Memorializing Ozzy with Mushrooms 

It’s hard to believe that it was 26 years ago when Ozzy graced these pages with an interview. An interview, by the way, that showed Ozzy’s true personality: not an arrogant “Rock God” or untouchable celebrity, but a genuinely funny, approachable, and gracious man.  Something that I think all of his fans already knew, but it was nice to see that person break proverbial bread with High Times

Last week, Kyle Rosner published a beautiful piece highlighting Ozzy’s life, and of course, his love of our favorite plant. But today, I want to share with you something that’s been on my mind since Ozzy went gently into that good night.

Given Ozzy’s hardcore partying days and extreme drug use – which was likely enough to kill a Tsavo Lion – it’s hard to believe that the thing that did him in was Parkinson’s Disease: a debilitating neurodegenerative disorder that, after being identified as a real medical condition in 1817, still has no cure.  Which is unfortunate, given that around 10 million people across the globe are currently living with this crippling condition.

To be sure, there are a number of pharmaceutical treatments that can help manage some of the symptoms of Parkinson’s Disease – but no actual cure. 

What may interest you, however, is that there is also growing evidence to suggest that psilocybin – the “special sauce” in magic mushrooms – could also help treat those suffering from Parkinson’s Disease. 

According to a clinical trial conducted by researchers at the University of California, San Francisco, Parkinson’s Disease patients who experience debilitating mood dysfunction in addition to their movement impairments (and didn’t respond well to other medications) found relief with psilocybin.

Participants of the study that were given psilocybin, “experienced clinically significant improvements in mood, cognition, and motor function that lasted for weeks after the drug was out of their systems.”  This is not trivial.

Of course, who knows if a specialized psilocybin treatment would’ve helped Ozzy live a longer, and less painful life in his later years? But certainly, we’re excited to see this amazing tryptamine alkaloid potentially offer an effective treatment for those desperately seeking relief from this horrible disease.  

Indeed, this is just more evidence that mushrooms are medicine and should be treated as such. 

This article is for informational and entertainment purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any treatment involving psychedelics or other controlled substances.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Pennsylvania: Reading City Council Adopts Municipal Decriminalization Ordinance

Published

on


pennsylvania marijuana laws

Members of the Reading (population: 95,000) city council have approved a municipal ordinance decriminalizing low-level marijuana possession offenses.

The ordinance, which passed by a 5-2 vote on Monday, imposes civil fines rather than criminal penalties for violations involving either the possession or use of up to 30 grams of marijuana. Under state law, marijuana possession is classified as a criminal misdemeanor, punishable by jail time.

Regional NORML coordinator Chris Goldstein spoke before the council in favor of the ordinance, opining that its adoption will save city resources and prevent thousands of low-level arrests. “Decriminalization is well proven, not just in Pennsylvania, but around the country,” he said. “One small arrest can have a huge impact [on people’s lives.]”

Numerous other Pennsylvania cities, including Erie, Harrisburg, Philadelphia, and Pittsburgh, have enacted similar ordinances.

Since 2018, nearly 90,000 Pennsylvanians have been arrested for violating state marijuana laws. Over 85 percent of those arrests were for marijuana possession.

Additional information on municipal decriminalization ordinances is available from NORML.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Federal Report Shows Youth Marijuana Use ‘Remained Stable’ Even As More States Legalized In Recent Years

Published

on


New federal health data indicate that while past-year marijuana use in the U.S. overall has climbed in recent years, the rise has been “driven by increases…among adults 26 years or older.” As for younger Americans, rates of both past-year use and cannabis use disorder, by contrast, “remained stable among adolescents and young adults between 2021 and 2024.”

In fact, past-year use among people ages 12 to 20 fell to a four-year low in 2024, the data show—even as a growing number of states enact laws legalizing marijuana for people over the age of 21. The results are contrary to arguments voiced by prohibitionist advocates who have long argued that it is important to keep cannabis illegal for adults in order to prevent youth use.

The data published by the Substance Abuse and Mental Health Services Administration (SAMHSA) come from the agency’s release of results from the latest National Survey on Drug Use and Health (NSDUH), which annually since 1971 has asked Americans ages 12 and older questions about their drug use, mental health and related treatment.

“The annual NSDUH provides timely statistical information on substance use and mental health in the U.S.,” SAMHSA Principal Deputy Assistant Secretary Art Kleinschmidt said in an agency press release Monday. “These data are incredibly valuable to researchers, clinicians, policymakers, and others, allowing for greater understanding of the nation’s behavioral health, and to help inform actions in support of President Trump’s vision to Make America Healthy Again.”

Among all respondents, the poll found, self-reported marijuana use within the past 12 months rose from 19.0 percent in 2021 to 22.3 percent last year.

While the SAMHSA press release sent on Monday about the report doesn’t highlight different trends by age levels, companion data from the survey distinguish the overall rise in marijuana use from stable or declining trends among “underage” Americans, aged 12 to 20.

In 2024, the reported rate of past-year cannabis use among that age group was 16.7 percent, hitting a four-year low.

The rate rose between 2021 (17.9 percent) and 2022 (19.2 percent), then fell during the next to years to 18.4 percent in 2023 and 16.7 percent last year.

2024 National Survey on Drug Use and Mental Health, SAMHSA

Between 2021 and 2024, the states of Connecticut, Delaware, Maryland, Minnesota, Missouri, New Mexico, New York, Ohio, Rhode Island and Virginia all legalized cannabis for adults over 21 year of age.

A supporting graphic in from SAMHSA also breaks down use by age group somewhat.

It shows that young adults, ages 18 to 25, remain most likely to have used marijuana in the past year, at 35 percent—though that rate was lower than at any other point since 2021.

About 1 in 10 young people ages 18 to 25 (10.4 percent) reported past-year use, meanwhile—also lower than at any other time over the four-year period.

2024 National Survey on Drug Use and Mental Health, SAMHSA

SAMHSA cautioned that given increases in adult use of marijuana, the generally stable trends among youth use shouldn’t be taken for granted.

“The increases in past-year illicit drug use and past-year drug use disorders are largely driven by increases in marijuana use and marijuana use disorder among adults 26 years or older,” the federal report says. “Although marijuana use and use disorder trends remained stable among adolescents and young adults between 2021 and 2024, the increase in adult use is important to inform prevention and treatment activities given changing attitudes around marijuana use and the shifting state policy landscape which has increased risk for marijuana use and use disorder among young people, and enabled the ready availability of high-potency marijuana products linked to negative health impacts in communities across the country.”

Other notable substance-related findings from the new survey include that past-year use of hallucinogens increased among all Americans 12 and older, from 2.7 percent in 2021 to 3.6 percent last year.

Past-year cocaine use declined slightly over the same time period, from 1.7 percent to 1.5 percent. Prescription opioid misuse also diminished from 3.0 percent to 2.6 percent.

People with any sort of drug use disorder during the past year, meanwhile, increased from 8.7 precent to 9.8 percent. Those figures do not include alcohol use disorder, which decreased from 10.6 percent to 9.7 percent.

Overall, 16.8 percent of Americans—48.4 million people—reported some sort of substance use disorder in 2024, the NSDUH data show.

Questions related to recovery, meanwhile, found that “1.7 million adults aged 18 or older (or 12.2%) perceived that they ever had a problem with their use of alcohol or drugs,” SAMHSA said. “Among these adults, 74.3% (or 23.5 million people) considered themselves to be in recovery or to have recovered.”

2024 National Survey on Drug Use and Mental Health, SAMHSA

Other questions looked at modes of marijuana use, finding that combustion remains the most popular form of consumption, with 73.9 percent of cannabis users reporting smoking within the past year. About half (49.8 percent) ate or drank cannabis products, while 39.8 reported vaping, 14.1 reported dabbing and 14.1 reported “some other mode of marijuana use.”

Respondents were able to choose as many responses to that question as applied.

As for vaping specifically, the data show it’s especially common among younger marijuana users, with 71.1 percent of respondents 12 to 17 saying they vaped cannabis in the past year. Among those 18 to 25, 52.0 percent said they had vaped, meanwhile, as did 33.0 percent of those 26 or older.

2024 National Survey on Drug Use and Mental Health, SAMHSA

Overall, 38.0 percent of cannabis consumers 12 and older said they vaped marijuana in 2024, while 62.0 percent said they used cannabis but did not vape.

SAMHSA’s report on the NSDUH findings a year ago also included a longer-term look at marijuana use trends, finding that youth use appeared to have fallen significantly in the preceding decade, as dozens of states legalized marijuana for adult or medical use.

The percentage of young people aged 12 to 17 who had ever tried marijuana, for example, dropped by 18 percent from 2014—when the first legal recreational cannabis sales in the U.S. launched—to 2023. Past-year and past-month use rates among young people also declined during that time period.

While the NSDUH survey has been conducted for decades, its methodology has changed over the years, making some historical comparisons difficult or impossible. Data from recent years, including 2023, 2022 and 2021 “should not be combined with data from 2020 or prior years for a variety of methodological reasons,” a SAMHSA spokesperson said last year in an email about that report.

A year earlier, in 2022, NSDUH for the first time asked respondents about their methods of marijuana consumption—including “smoking; vaping; dabbing waxes, shatter, or concentrates; eating or drinking; putting drops, strips, lozenges, or sprays in their mouth or under their tongue; applying lotion, cream, or patches to their skin; taking pills; or some other way.”

Release of the latest NSDUH data comes on the heels of a SAMHSA webinar earlier this month in which a Johns Hopkins University researcher acknowledged that self-reported cannabis consumption by adults has risen as more states have legalized, while use by youth has generally remained flat or fallen.

“Use among youth is one of the biggest areas of concern related to the legalization and increased accessibility of cannabis,” the presenter said, “but surprisingly, that cohort has actually maintained relatively stable [for] both past-year and daily use.”

A separate secret shopper study out of New York City earlier this year found that state-licensed marijuana retailers were far more consistent about discouraging youth access to cannabis compared to illicit stores, with regulated outlets consistently verifying the age of would-be buyers as well as avoiding cartoon signage and products that appeal to young people.

All of the licensed retailers that were observed checked purchasers’ ID both before store entry and prior to purchase, that study found. Unregulated stores, by contrast, checked IDs before entry only 10 percent of the time, and verified ages before purchase less than half (48 percent) of the time.

Across the U.S., research suggests that marijuana use by young people has generally fallen in states that legalize the drug for adults.

A report from the advocacy group Marijuana Policy Project (MPP), for example, found that youth marijuana use declined in 19 out of 21 states that legalized adult-use marijuana—with teen cannabis consumption down an average of 35 percent in the earliest states to legalize.

The report cited data from a series of national and state-level youth surveys, including the annual Monitoring the Future (MTF) Survey, which is supported by the National Institute on Drug Abuse (NIDA).

The latest version of the MTF, released late last year, found that cannabis use among eighth, 10th and 12 graders is now lower than before the first states started enacting adult-use legalization laws in 2012. There was also a significant drop in perceptions by youth that cannabis is easy to access in 2024 despite the widening adult-use marketplace.

Another survey from the U.S. Centers for Disease Control and Prevention (CDC) last year also showed a decline in the proportion of high-school students reporting past-month marijuana use over the past decade, as dozens of states moved to legalize cannabis.

At the state level, MPP’s assessment looked at research such as the Washington State Healthy Youth Survey that was released in April 2024.

That survey showed declines in both lifetime and past-30-day marijuana use in recent years, with striking drops that held steady through 2023. The results also indicated that perceived ease of access to cannabis among underage students has generally fallen since the state enacted legalization for adults in 2012—contrary to fears repeatedly expressed by opponents of the policy change.

In June of last year, meanwhile, the biannual Healthy Kids Colorado Survey found that rates of youth marijuana use in the state declined slightly in 2023—remaining significantly lower than before the state became one of the first in the U.S. to legalize cannabis for adults in 2012.

The findings broadly track with other past surveys that have investigated the relationship between jurisdictions that have legalized marijuana and youth cannabis use.

For example, a Canadian government report recently found that daily or near-daily use rates by both adults and youth have held steady over the last six years after the country enacted legalization.

Another U.S. study reported a “significant decrease” in youth marijuana use from 2011 to 2021—a period in which more than a dozen states legalized marijuana for adults—detailing lower rates of both lifetime and past-month use by high-school students nationwide.

Another federal report published last summer concluded that cannabis consumption among minors—defined as people 12 to 20 years of age—fell slightly between 2022 and 2023.

Separately, a research letter published by the Journal of the American Medical Association (JAMA) in April 2024 said there’s no evidence that states’ adoption of laws to legalize and regulate marijuana for adults have led to an increase in youth use of cannabis.

Another JAMA-published study earlier that month that similarly found that neither legalization nor the opening of retail stores led to increases in youth cannabis use.

In 2023, meanwhile, a U.S. health official said that teen marijuana use has not increased “even as state legalization has proliferated across the country.”

Another earlier analysis from the U.S. Centers for Disease Control and Prevention found that rates of current and lifetime cannabis use among high school students have continued to drop amid the legalization movement.

A separate NIDA-funded study published in the American Journal of Preventive Medicine in 2022 also found that state-level cannabis legalization was not associated with increased youth use. The study demonstrated that “youth who spent more of their adolescence under legalization were no more or less likely to have used cannabis at age 15 years than adolescents who spent little or no time under legalization.”

Yet another 2022 study from Michigan State University researchers, published in the journal PLOS One, found that “cannabis retail sales might be followed by the increased occurrence of cannabis onsets for older adults” in legal states, “but not for underage persons who cannot buy cannabis products in a retail outlet.”

The trends were observed despite adult use of marijuana and certain psychedelics reaching “historic highs” in 2022, according to separate 2023 data.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
featured15 minutes ago

Ozzy Osbourne, Parkinson’s and the Promise of Magic Mushrooms: Could They Have Helped?

featured1 hour ago

Pennsylvania: Reading City Council Adopts Municipal Decriminalization Ordinance

video2 hours ago

VIDEO: Guest Smokes Weed on Mario Kart After Attraction Breaks Down At Universal Studios Hollywood

featured2 hours ago

Federal Report Shows Youth Marijuana Use ‘Remained Stable’ Even As More States Legalized In Recent Years

video3 hours ago

Cannabis ballot initiative brings lawsuit to Menominee

featured3 hours ago

Proposed DOJ Rule Says Marijuana Users Likely Wouldn’t Be Eligible To Have Gun Rights Restored

video4 hours ago

Kentucky medical marijuana cultivator brings in half-grown plants to speed harvest

featured4 hours ago

Federal Researchers Claim First-Ever Detection Of Cannabinoids In Human Breath After Use Of Marijuana Edibles

featured5 hours ago

BREEDING FOR BIG BUDS (1986)

featured9 hours ago

New DEA Admin Sidelines Cannabis Rescheduling Despite Earlier Promises

featured10 hours ago

New Rules in New Zealand Place Strict Guidelines on Medical Cannabis ‘Advertising’ 

video10 hours ago

South Beloit blood donors get marijuana products for their contribution

featured11 hours ago

Oklahoma Campaign to Legalize Adult-Use Cannabis Will Begin Collecting Signatures Next Month 

video11 hours ago

Bellbrook leaders pass ordinance banning marijuana sales

featured12 hours ago

PackworldUSA Highlights Versatile, Precision-Driven 3400 Series Heat Sealer for Cannabis Applications

featured13 hours ago

Federal Court Sides With Safe Drug Consumption Site, Saying Religious Protections Apply

featured14 hours ago

Trump’s New DEA Administrator Omits Cannabis Rescheduling From Top Priorities

featured15 hours ago

High Times, RAW and hhemp.co Forge New Era of Pre‑Rolls, Vapes & Hemp Products

featured16 hours ago

Bill To Ban Hemp Products With THC Is Filed In Texas House, As Governor Continues To Call For Regulations Instead

video17 hours ago

Illness linked to cannabis use sending more patients to the hospital, including NC woman

featured17 hours ago

Chicagoland Cookies Dispensary Opens in Illinois

featured18 hours ago

Is the Wait Over for Colombian Patients? Government May Allow Sale of Medical Cannabis Flowers

featured19 hours ago

NORML Remembers Richard Lee – NORML

featured20 hours ago

Bipartisan Coalition of 32 Attorneys General Call for Federal Cannabis Banking Reforms

California Cannabis Updates1 year ago

Alert: Department of Cannabis Control updates data dashboards with full data for 2023 

Breaking News1 year ago

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

best list12 months ago

5 best CBD creams of 2024 by Leafly

Business10 months ago

EU initiative begins bid to open access to psychedelic therapies

Bay Smokes1 year ago

Free delta-9 gummies from Bay Smokes

cbd1 year ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

autoflower seeds10 months ago

5 best autoflower seed banks of 2024 by Leafly

California1 year ago

May 2024 Leafly HighLight: Pink Runtz strain

Breaking News1 year ago

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Mississippi Cannabis News1 year ago

Mississippi city official pleads guilty to selling fake CBD products

cannabis brands10 months ago

Discover New York’s dankest cannabis brands [September 2024]

Mississippi Cannabis News1 year ago

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Mississippi Cannabis News1 year ago

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Hemp1 year ago

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Breaking News1 year ago

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

best list1 year ago

5 best THC drinks of 2024 by Leafly

Arkansas10 months ago

The Daily Hit: October 2, 2024

best list1 year ago

6 best CBD gummies of 2024 by Leafly

best list1 year ago

5 best delta-9 THC gummies of 2024 by Leafly

Breaking News1 year ago

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

Mississippi Cannabis News1 year ago

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

Breaking News1 year ago

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Asia Pacific & Australia1 year ago

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

California Cannabis Updates1 year ago

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair

Trending